Tuesday, September 11, 2012 at 11:30 a.m. Eastern
ARLINGTON, Tenn.--(BUSINESS WIRE)--Aug. 29, 2012--
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical
device company, announced today that it will be participating in the
Morgan Stanley Global Healthcare Conference on Tuesday, September 11,
2012 at the Grand Hyatt Hotel in New York, NY. Robert Palmisano,
President and Chief Executive Officer, will present at 11:30 a.m.
A live audio webcast of the conference presentation, along with the
accompanying presentation materials, will be available on Wright’s
corporate website at www.wmt.com/corporate,
under the “Investor Info” link. The audio webcast and accompanying
presentation materials will be archived on this site under the “Investor
Presentations” link following the conference.
About Wright Medical
Wright Medical Group, Inc. is a global orthopaedic medical device
company and a leading provider of surgical solutions for the foot and
ankle market. The Company specializes in the design, manufacture and
marketing of devices and biologic products for extremity, hip and knee
repair and reconstruction. The Company has been in business for more
than 60 years and markets its products in over 60 countries worldwide.
For more information about Wright Medical, visit the Company’s website
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
The conference call and webcast may contain “forward-looking
statements” as defined under U.S. federal securities laws. These
statements reflect management’s current knowledge, assumptions, beliefs,
estimates, and expectations and express management’s current views of
future performance, results, and trends and may be identified by their
use of terms such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and
other similar terms. Forward-looking statements are subject to a
number of risks and uncertainties that could cause our actual results to
materially differ from those described in the forward-looking statements.
Such risks and uncertainties include the impact of Wright's
settlement of the federal investigation into Wright's consulting
arrangements with orthopaedic surgeons relating to its hip and knee
products in the United States, including Wright's compliance with a
Deferred Prosecution Agreement through September 2012 and a Corporate
Integrity Agreement through September 2015, and those risks and
uncertainties discussed in our filings with the Securities and Exchange
Commission (including those described in Item 1A of our Annual Report on
Form 10-K for the year ended December 31, 2011 and our Quarterly Report
on Form 10-Q for the quarter ended June 30, 2012, under the heading
“Risk Factors” and elsewhere), including demand for and market
acceptance of our new and existing products; future actions of
governmental authorities and other third parties; tax measures; business
development and growth opportunities; product quality or patient safety
issues; products liability claims; enforcement of our intellectual
property rights; the geographic and product mix impact on our sales;
retention of sales representatives and independent distributors;
inventory reductions or fluctuations in buying patterns by wholesalers
or distributors; ability to realize the anticipated benefits of
restructuring initiatives; and impact of the commercial and credit
environment on us and our customers and suppliers. Readers should
not place undue reliance on forward-looking statements.
Source: Wright Medical Group, Inc.
Wright Medical Group, Inc.
Julie D. Tracy, 901-290-5817
Vice President, Chief Communications Officer